European Patent Office

T 0399/11 (dsRNA feeding delivery method RNAi/DEVGEN) vom 26.01.2015

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2015:T039911.20150126
Datum der Entscheidung
26. Januar 2015
Aktenzeichen
T 0399/11
Online am
11. März 2015
Antrag auf Überprüfung von
-
Anmeldenummer
01129274.5
Verfahrenssprache
Englisch
Verteilung
Nicht verteilt (D)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
Characterisation of gene function using double stranded RNA inhibition
Name des Antragstellers
Devgen NV
Name des Einsprechenden
BASF SE
Kammer
3.3.08
Leitsatz
-
Relevante Rechtsnormen
European Patent Convention Art 123(2)European Patent Convention Art 83European Patent Convention R 114(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)
Schlagwörter
Main Request - admissibility (yes);
Main Request - added subject-matter (no)
Main Request - sufficiency of disclosure (yes)
Main Request - priority entitlement (yes)
Main Request - novelty and inventive step (yes)
Admissibility fresh case (no)
Orientierungssatz
-
Zitierte Akten
-
Zitierende Akten
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the department of first instance with the order to maintain the patent as amended in the following version:

Description:

pages 5 - 10 and 12 - 74 of the patent specification as granted;

pages 3, 4, 11 and 75 of the amended patent specification as filed during the oral proceedings on 26 January 2015.

Claims:

claims 1 - 12 of the Main Request, filed under cover of a letter dated 24 December 2014.

Drawings:

Figures 1 - 19 of the patent as granted.